Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care Razvan DiaconescuRainer Storb Review 28 September 2004 Pages: 1 - 13
Expression of e-cadherin in high-risk breast cancer Eugene M. HowardStephen K. LauRuby Kochhar Original Paper 01 October 2004 Pages: 14 - 18
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer Shunji MatsumuraNaohide OueWataru Yasui Original Paper 30 September 2004 Pages: 19 - 25
A rationale for neoadjuvant systemic treatment followed by surgical assessment and intraperitoneal chemotherapy in patients presenting with non-surgically resectable ovarian or primary peritoneal cancers Maurie MarkmanJerome Belinson Original Paper 21 September 2004 Pages: 26 - 30
Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme Jochen TuettenbergRainer GrobholzPeter Vajkoczy Original Paper 28 September 2004 Pages: 31 - 40
Increased expression of ADAM family members in human breast cancer and breast cancer cell lines Uwe LendeckelJana KohlChristoph Röcken Original Paper 30 September 2004 Pages: 41 - 48
Listeria monocytogenes produces a pro-invasive factor that signals via ErbB2/ErbB3 heterodimers Maria José OliveiraTineke LauwaetAncy Leroy Original Paper 08 October 2004 Pages: 49 - 59
The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain Knut LiepeRoswitha RungeJörg Kotzerke Original Paper 22 September 2004 Pages: 60 - 66
Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer Michael StahlHansjochen WilkeUdo Vanhoefer Original Paper 05 October 2004 Pages: 67 - 72